Uniphos Enter.

Has Uniphos Enter. declared dividend?

Uniphos Enterprises Ltd has declared a 285% dividend, amounting to ₹5.7 per share, with an ex-date of September 6, 2024. The company has shown strong total returns across various periods, particularly a 225.14% total return over the past five years.

Uniphos Enterprises Ltd has declared a 285% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 285%<BR>- Amount per share: 5.7<BR>- Ex-date: 06 Sep 2024<BR><BR>Dividend Yield: 3.56%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 0.95%, with no dividend return, resulting in a total return of 0.95%.<BR><BR>For the 1-year period, the price return was 0.25%, with a dividend return of 3.45%, leading to a total return of 3.7%.<BR><BR>Over the 2-year period, the price return was 4.95%, the dividend return was 7.66%, culminating in a total return of 12.61%.<BR><BR>In the 3-year period, the price return was 28.23%, with a dividend return of 14.76%, resulting in a total return of 42.99%.<BR><BR>During the 4-year period, the price return was 32.78%, the dividend return was 16.29%, leading to a total return of 49.07%.<BR><BR>Finally, in the 5-year period, the price return was 189.62%, with a dividend return of 35.52%, resulting in a total return of 225.14%.<BR><BR>Overall, Uniphos Enterprises Ltd has shown a strong commitment to returning value to shareholders through its significant dividend declaration and has demonstrated positive total returns across all periods, particularly over the longer term.

Who are the peers of the Uniphos Enter.?

Uniphos Enterprises' peers include Coal India, Doms Industries, Sandur Manganese, and others, with varying management risks and growth rates. Doms Industries leads in 1-year returns at 32.50%, while Uniphos has a return of 8.59%.

Peers: The peers of Uniphos Enter. are Coal India, Doms Industries, Sandur Manganese, Navneet Educat., Flair Writing, Kokuyo Camlin, Linc, Vasa Denticity, Creative Newtech.<BR><BR>Quality Snapshot: Excellent management risk is observed at Coal India, Sandur Manganese, while Good management risk is found at Doms Industries. Average management risk is present at Navneet Educat., Flair Writing, Kokuyo Camlin, Linc, Vasa Denticity, Creative Newtech, and the rest. Below Average management risk is attributed to Uniphos Enter. Growth is Excellent for Coal India, Doms Industries, and Sandur Manganese, while Below Average growth is noted for Navneet Educat., Flair Writing, Uniphos Enter., Kokuyo Camlin, and the rest. Average growth is seen at Linc, while Excellent growth is observed at Vasa Denticity. Capital Structure is Excellent for Coal India, Doms Industries, Sandur Manganese, and Linc, while Below Average capital structure is noted for Uniphos Enter., Kokuyo Camlin, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Doms Industries at 32.50%, while the lowest is Coal India at -23.41%. Uniphos Enter. has a 1-year return of 8.59%, which is higher than Coal India but lower than Doms Industries. Additionally, peers with a negative six-month return include Kokuyo Camlin and Sandur Manganese.

Who are in the management team of Uniphos Enter.?

As of March 2023, the management team of Uniphos Enter includes R D Shroff (Managing Director), S R Shroff (Vice Chairperson), J R Shroff (Non-Executive Director), A C Ashar (Chairman), Pradeep Goyal and Swati S Mayekar (Non-Executive Independent Directors), and K M Thacker (Company Secretary & Compliance Officer). Each member contributes to the company's governance and oversight.

As of March 2023, the management team of Uniphos Enter consists of the following individuals:<BR><BR>1. R D Shroff - Managing Director<BR>2. S R Shroff - Vice Chairperson<BR>3. J R Shroff - Non-Executive & Non-Independent Director<BR>4. A C Ashar - Chairman (Non-Executive)<BR>5. Pradeep Goyal - Non-Executive & Independent Director<BR>6. Swati S Mayekar - Non-Executive & Independent Director<BR>7. K M Thacker - Company Secretary & Compliance Officer<BR><BR>Each member plays a distinct role in the governance and oversight of the company.

What does Uniphos Enter. do?

Uniphos Enterprises Ltd is a small-cap company that manufactures specialty chemicals, including phosphorus compounds and pesticides. As of March 2025, it reported net sales of 729 Cr and a net profit of -16 Cr, with a market cap of INR 1,064 Cr.

Overview:<BR>Uniphos Enterprises Ltd is a small-cap company in the miscellaneous industry, primarily engaged in the manufacturing of specialty chemicals, including phosphorus compounds, pesticides, dyes, and mercury salts.<BR><BR>History:<BR>Established in 1969 as United Phosphorus Limited, the company has evolved over the years, changing its name to Uniphos Enterprises Limited. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 729 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: -16 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 1,064 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 1,064.00<BR>- Industry P/E: 35<BR>- Dividend Yield: 3.69%<BR>- Debt Equity: -0.01<BR>- Return on Equity: 0.01%<BR>- Price to Book: 0.42<BR><BR>Contact Details:<BR>Address: 11 GIDC, Valsad Dist VAPI Gujarat : 396195<BR>Tel: 91-0260-2400717<BR>Email: thackerkm@uniphos.com<BR>Website: http://www.uelonline.com

Who are the top shareholders of the Uniphos Enter.?

The top shareholders of Uniphos Enterprises include Nerka Chemicals Pvt Ltd with 73.29%, 15 Foreign Institutional Investors holding 15.72%, and Ares Diversified as the largest public shareholder at 4.56%. Individual investors own 8.91%, with no pledged promoter holdings reported.

The top shareholders of Uniphos Enterprises include the promoters, with Nerka Chemicals Pvt Ltd holding the largest share at 73.29%. Additionally, 15 Foreign Institutional Investors (FIIs) collectively hold 15.72% of the shares. The highest public shareholder is Ares Diversified, which owns 4.56%. Individual investors account for 8.91% of the shareholding. There are no pledged promoter holdings reported.

How big is Uniphos Enter.?

As of 24th July, Uniphos Enterprises Ltd has a market capitalization of 1,133.00 Cr, with Net Sales of 111.51 Cr and a Net Profit of 0.27 Cr reported in the latest four quarters. Shareholder's Funds are 2,075.45 Cr and Total Assets are 2,056.04 Cr as of March 2024.

As of 24th July, Uniphos Enterprises Ltd has a market capitalization of 1,133.00 Cr, categorizing it as a Small Cap company.<BR><BR>In the latest four quarters, Uniphos Enterprises Ltd reported Net Sales of 111.51 Cr and a Net Profit of 0.27 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 2,075.45 Cr and Total Assets totaling 2,056.04 Cr.

How has been the historical performance of Uniphos Enter.?

Uniphos Enter. has shown significant sales growth, with net sales rising from 1.47 Cr in March 2023 to 111.51 Cr in March 2025. However, it faces profitability challenges, as operating profit declined and cash flow from operations remained negative.

Answer:<BR>The historical performance of Uniphos Enter. shows significant fluctuations in its financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Uniphos Enter. experienced a dramatic increase in net sales from 1.47 Cr in March 2023 to 111.51 Cr in March 2025, reflecting a substantial growth trajectory. However, the total expenditure also rose sharply, leading to an operating profit (PBDIT) of 2.29 Cr in March 2025, down from 39.78 Cr in March 2024. This decline in operating profit is accompanied by a negative operating profit margin of -3.43% in March 2025, indicating challenges in managing costs relative to revenue. Profit before tax decreased to 0.23 Cr in March 2025 from 38.94 Cr in March 2024, while profit after tax also fell to 0.28 Cr from 38.61 Cr in the previous year. The company's reserves increased to 2,727.74 Cr in March 2025, up from 2,061.54 Cr in March 2024, yet the book value per share adjusted to 373.37 in March 2025 from 277.58 in March 2024. Cash flow from operating activities remained negative at -2.00 Cr in March 2025, although cash flow from investing activities improved to 52.00 Cr. Overall, while Uniphos Enter. has shown remarkable sales growth, it faces challenges in profitability and cash flow management.

Is Uniphos Enter. technically bullish or bearish?

As of December 4, 2025, the technical trend has shifted to a moderately strong bearish stance, driven by bearish MACD, Bollinger Bands, and moving averages, despite a mildly bullish OBV signal on the monthly chart.

As of 4 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands on both weekly and monthly charts, and bearish moving averages on the daily chart. The KST is also bearish across both timeframes. Although the OBV shows a mildly bullish signal on the monthly, it does not outweigh the overall bearish indicators.

When is the next results date for Uniphos Enterprises Ltd?

The next results date for Uniphos Enterprises Ltd is February 6, 2026.

The next results date for Uniphos Enterprises Ltd is scheduled for February 6, 2026.

Are Uniphos Enterprises Ltd latest results good or bad?

Uniphos Enterprises Ltd's latest Q2 FY26 results are concerning, showing a net profit of ₹23.16 crores driven solely by a significant increase in other income, with zero operational revenue and an operating loss of ₹1.10 crores. This indicates weak profitability and raises red flags about the company's future prospects.

Uniphos Enterprises Ltd's latest results for Q2 FY26 present a concerning picture. While the company reported a net profit of ₹23.16 crores, this figure is misleading as it is primarily driven by a significant spike in other income, which amounted to ₹24.43 crores. This represents an extraordinary increase of 8,948% from the previous quarter but does not stem from any operational revenue, as the company reported zero revenue for the quarter. This marks a complete collapse from ₹5.86 crores in the prior quarter and ₹30.48 crores in the same period last year.<BR><BR>The operational performance is troubling, with the company showing no sales activity and an operating loss before other income of ₹1.10 crores. The return on equity (ROE) is also very low at 0.67%, indicating weak profitability relative to its equity base. Additionally, the stock has declined nearly 30% over the past year, reflecting broader concerns about its operational viability.<BR><BR>In summary, while the reported profit may seem positive at first glance, it is not indicative of a healthy business, as it relies entirely on non-operational income. The absence of revenue generation and the company's transformation into an investment holding entity rather than an active manufacturer raise significant red flags about its future prospects.

Should I buy, sell or hold Uniphos Enterprises Ltd?

Why is Uniphos Enterprises Ltd falling/rising?

As of 02-Apr, Uniphos Enterprises Ltd's stock price is at 96.49, reflecting a 1.57% increase. The stock has shown short-term gains but faces declining investor interest and mixed signals regarding its longer-term trend.

As of 02-Apr, Uniphos Enterprises Ltd's stock price is rising, currently at 96.49, reflecting a change of 1.49 (1.57%) upward. This increase is supported by the stock's performance today, where it has outperformed its sector by 0.76% and has gained consecutively over the last three days, resulting in a total return of 5.68% during this period. The stock opened with a significant gain of 5.26% today and reached an intraday high of Rs 100.<BR><BR>Despite this positive movement, the stock has experienced high volatility today, with an intraday volatility of 5.41%. Additionally, it is important to note that the stock's delivery volume has decreased significantly, falling by 93.88% against the 5-day average, indicating a decline in investor participation. While the stock is currently above its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages, suggesting mixed signals regarding its longer-term trend. Overall, the recent gains can be attributed to short-term trading activity, despite the broader context of declining investor interest.

Which are the latest news on Uniphos Enter.?